These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7656625)

  • 61. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
    Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
    Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia.
    Bar-Aluma BE; Efrati O; Kaufmann H; Palma JA; Norcliffe-Kaufmann L
    Lung; 2018 Feb; 196(1):93-101. PubMed ID: 29234869
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Hajiro T; Mishima M; Izumi T
    Respiration; 1999; 66(2):119-23. PubMed ID: 10202314
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of salbutamol on oxygen saturation in COPD.
    Charoenratanakul S; Borrirukwanit K
    J Med Assoc Thai; 1996 Apr; 79(4):218-21. PubMed ID: 8708506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease.
    Arfè A; Nicotra F; Cerveri I; de Marco R; Vaghi A; Merlino L; Corrao G
    COPD; 2016 Oct; 13(5):540-6. PubMed ID: 26934569
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients.
    Dhand R; Duarte AG; Jubran A; Jenne JW; Fink JB; Fahey PJ; Tobin MJ
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):388-93. PubMed ID: 8756811
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Response to bronchodilators.
    Shim C
    Clin Chest Med; 1989 Jun; 10(2):155-64. PubMed ID: 2567648
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
    Rennard SI; Serby CW; Ghafouri M; Johnson PA; Friedman M
    Chest; 1996 Jul; 110(1):62-70. PubMed ID: 8681667
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED; van Dyk M; Sagriotis A
    Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Airway blood flow reactivity in smokers.
    Wanner A; Campos MA; Mendes E
    Pulm Pharmacol Ther; 2007; 20(2):126-9. PubMed ID: 16414297
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Lung; 2006; 184(4):217-22. PubMed ID: 17006748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High resolution computed tomography (HRCT) assessment of beta 2-agonist induced bronchodilation in chronic obstructive pulmonary disease patients.
    De Luca N; Capuzi P; D'Angeli AL; D'Antoni L; Pavone P; De Santis M; Di Girolamo M; Catalano C; Passariello R
    Eur Rev Med Pharmacol Sci; 1999; 3(2):83-7. PubMed ID: 10827809
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnosing obstructive lung disease. Why is differentiating COPD from asthma important?
    Subramanian D; Guntupalli KK
    Postgrad Med; 1994 Jun; 95(8):69-70, 75-8, 83-5. PubMed ID: 8202424
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early detection of COPD in a high-risk population using spirometric screening.
    Zieliñski J; Bednarek M;
    Chest; 2001 Mar; 119(3):731-6. PubMed ID: 11243950
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Underutilization of Pulmonary Function Testing in Veterans Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation: Who are We Missing?
    Bade BC; DeRycke EC; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Cain HC; Brandt C; Bastian LA; Akgün KM
    COPD; 2020 Feb; 17(1):15-21. PubMed ID: 31948267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.